Found: 125
Select item for more details and to access through your institution.
Prevalence, clinical features, and survival outcome trends of 627 patients with primary cutaneous lymphoma over 29 years: a retrospective review from single tertiary center in Korea.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-71210-y
- By:
- Publication type:
- Article
Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 6, p. 1989, doi. 10.1007/s00277-023-05603-w
- By:
- Publication type:
- Article
CT Demonstration of Local Cytokine-Release Syndrome Involving the Head and Neck Following Chimeric Antigen Receptor T Cell Infusion Therapy.
- Published in:
- Korean Journal of Radiology, 2024, v. 25, n. 4, p. 399, doi. 10.3348/kjr.2023.1100
- By:
- Publication type:
- Article
The Prognostic Significance of Vitamin D Deficiency in Korean Patients With Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. e112, doi. 10.1016/j.clml.2023.12.002
- By:
- Publication type:
- Article
A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1282323
- By:
- Publication type:
- Article
Radioimmunotherapy with <sup>131</sup>I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 6, p. 690, doi. 10.1111/ajco.13932
- By:
- Publication type:
- Article
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1230629
- By:
- Publication type:
- Article
Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and lenalidomide/rituximab (R2) based on real‑world data in patients with relapsed/refractory diffuse large B‑cell lymphoma
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
- Published in:
- Annals of Hematology, 2023, v. 102, n. 7, p. 1773, doi. 10.1007/s00277-023-05196-4
- By:
- Publication type:
- Article
Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
- By:
- Publication type:
- Article
Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 693, doi. 10.4143/crt.2022.952
- By:
- Publication type:
- Article
A Patient With CD20-positive T-cell Lymphoma Concurrently Exhibiting B-cell Neoplasm-related Genetic Abnormalities Shows Clonal Escape Post CD20-targeting Treatment.
- Published in:
- Annals of Laboratory Medicine, 2023, v. 43, n. 2, p. 200, doi. 10.3343/alm.2023.43.2.200
- By:
- Publication type:
- Article
Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 325, doi. 10.4143/crt.2022.008
- By:
- Publication type:
- Article
Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168
- By:
- Publication type:
- Article
Correction to: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805).
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 1, p. 110, doi. 10.1007/s12185-022-03332-w
- By:
- Publication type:
- Article
Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 6, p. 1217, doi. 10.1007/s00277-022-04776-0
- By:
- Publication type:
- Article
Comparison of clinical and laboratory characteristics of nonsecretory multiple myeloma and secretory multiple myeloma in a tertiary care hospital.
- Published in:
- International Journal of Laboratory Hematology, 2022, v. 44, n. 3, p. 582, doi. 10.1111/ijlh.13811
- By:
- Publication type:
- Article
P-118: Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S99, doi. 10.1016/S2152-2650(21)02245-X
- By:
- Publication type:
- Article
Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Poster: ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S239, doi. 10.1016/S2152-2650(21)01499-3
- By:
- Publication type:
- Article
ABCL-346: Overall Survival with Tafasitamab + Lenalidomide (LEN) vs Routinely Administered Therapies for ASCT-Ineligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Outcomes from the Observational RE-MIND2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S392, doi. 10.1016/S2152-2650(21)01891-7
- By:
- Publication type:
- Article
Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 3, p. 847, doi. 10.4143/crt.2020.1060
- By:
- Publication type:
- Article
The limited role of comprehensive staging work‐up in ocular adnexal extranodal marginal zone lymphoma of mucosa‐associated lymphoid tissue type (MALToma) with excellent prognosis.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 848, doi. 10.1111/bjh.17411
- By:
- Publication type:
- Article
Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell Myeloma.
- Published in:
- Annals of Laboratory Medicine, 2021, v. 41, n. 3, p. 259, doi. 10.3343/alm.2021.41.3.259
- By:
- Publication type:
- Article
A prognostic index for extranodal marginal‐zone lymphoma based on the mucosa‐associated lymphoid tissue International Prognostic Index and serum β2‐microglobulin levels.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 307, doi. 10.1111/bjh.17222
- By:
- Publication type:
- Article
Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis.
- Published in:
- Cancer Communications, 2021, v. 41, n. 3, p. 275, doi. 10.1002/cac2.12150
- By:
- Publication type:
- Article
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01020-y
- By:
- Publication type:
- Article
Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders–diffuse large B-cell lymphoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82534-4
- By:
- Publication type:
- Article
Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 1, p. 270, doi. 10.4143/crt.2020.626
- By:
- Publication type:
- Article
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in newly diagnosed multiple myeloma: a systematic review and meta-analysis.
- Published in:
- European Radiology, 2021, v. 31, n. 1, p. 152, doi. 10.1007/s00330-020-07177-x
- By:
- Publication type:
- Article
Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 1, p. 81, doi. 10.1007/s12185-020-02988-6
- By:
- Publication type:
- Article
Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09).
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2831, doi. 10.1007/s00277-020-04284-z
- By:
- Publication type:
- Article
Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.594692
- By:
- Publication type:
- Article
Assessment of NK Cell Activity Based on NK Cell-Specific Receptor Synergy in Peripheral Blood Mononuclear Cells and Whole Blood.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 8112, doi. 10.3390/ijms21218112
- By:
- Publication type:
- Article
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non‐Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.
- Published in:
- Transplant International, 2020, v. 33, n. 10, p. 1211, doi. 10.1111/tri.13664
- By:
- Publication type:
- Article
First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2192, doi. 10.3390/cancers12082192
- By:
- Publication type:
- Article
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67738-4
- By:
- Publication type:
- Article
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical, Laboratory, and Bone Marrow Findings of 31 Patients With Waldenström Macroglobulinemia.
- Published in:
- Annals of Laboratory Medicine, 2020, v. 40, n. 3, p. 193, doi. 10.3343/alm.2020.40.3.193
- By:
- Publication type:
- Article
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 4, p. 413, doi. 10.1002/ajh.25726
- By:
- Publication type:
- Article
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30--Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 374, doi. 10.4143/crt.2019.198
- By:
- Publication type:
- Article
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00855-9
- By:
- Publication type:
- Article
Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00329
- By:
- Publication type:
- Article
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Role of whole-body MRI for treatment response assessment in multiple myeloma: comparison between clinical response and imaging response.
- Published in:
- 2020
- By:
- Publication type:
- journal article
JL1 Antigen Expression on Bone Marrow Lymphoma Cells from Patients With Non-Hodgkin Lymphoma.
- Published in:
- Annals of Laboratory Medicine, 2020, v. 40, n. 1, p. 1, doi. 10.3343/alm.2020.40.1.1
- By:
- Publication type:
- Article